Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis

European Journal of Human Genetics

Volumn 19, Issue 8, 2011, Pages 908-914

  Korotkova, Marina ^a   Daha, Nina A ^b   Seddighzadeh, Maria ^a   Ding, Bo ^c   Catrina, Anca I ^a   Lindblad, Staffan ^a   Huizinga, Tom W J ^b   Toes, Rene E M ^b   Alfredsson, Lars ^c   Klareskog, Lars ^a   Jakobsson, Per Johan ^a   Padyukov, Leonid ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME INDUCTION; FEMALE; GENE FUNCTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVIUM; UNIVARIATE ANALYSIS;

ADULT; AGE OF ONSET; AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, GENETIC; SEX FACTORS; SWEDEN; SYNOVIAL MEMBRANE;

EID: 79960652042     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.50     Document Type: Article

References (36)

1. Klareskog L, Alfredsson L, Rantapaa-Dahlqvist S, Berglin E, Stolt P, Padyukov L: What precedes development of rheumatoid arthritis? Ann Rheum Dis 2004; 63 (Suppl 2): ii28-ii31. (Pubitemid 39424655)
2. Gao XJ, Olsen NJ, Pincus T, Stastny P: HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum 1990; 33: 939-946. (Pubitemid 20226346)
3. Moreno I, Valenzuela A, Garcia A, Yelamos J, Sanchez B, Hernanz W: Association of the shared epitope with radiological severity of rheumatoid arthritis. J Rheumatol 1996; 23: 6-9. (Pubitemid 26035992)
4. Raychaudhuri S: Recent advances in the genetics of rheumatoid arthritis. Curr Opin Rheumatol 2010; 22: 109-118.
5. Halushka MK, Halushka PV: Toward individualized analgesic therapy: functional cyclooxygenase 1 and 2 haplotypes. Clin Pharmacol Ther 2006; 79: 404-406.
6. Skarke C, Schuss P, Kirchhof A, Doehring A, Geisslinger G, Lotsch J: Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance. Pharmacogenomics 2007; 8: 1643-1660.
7. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B: Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999; 96: 7220-7225. (Pubitemid 29299642)
8. Samuelsson B, Morgenstern R, Jakobsson P-J: Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 2007; 59: 207-224. (Pubitemid 47481434)
9. Kamei D, Yamakawa K, Takegoshi Y et al: Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J Biol Chem 2004; 279: 33684-33695. (Pubitemid 39063018)
10. Trebino C, Stock J, Gibbons C et al: Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 2003; 100: 9044-9049. (Pubitemid 36899220)
11. Stichtenoth DO, Thoren S, Bian H, Peters-Golden M, Jakobsson PJ, Crofford LJ: Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J Immunol 2001; 167: 469-474. (Pubitemid 32567813)
12. Korotkova M, Westman M, Gheorghe KR et al: Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway. Arthritis Rheum 2005; 52: 3439-3447. (Pubitemid 41612210)
13. Westman M, Korotkova M, af Klint E et al: Expression of microsomal prostaglandin E synthase in rheumatoid arthritis synovium. Arthritis Rheum 2004; 50: 1774-1780. (Pubitemid 38725089)
14. Hoeft B, Becker N, Deeg E, Beckmann L, Nieters A: Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma. Cancer Causes Control 2008; 19: 163-173.
15. Lemaitre RN, Rice K, Marciante K et al: Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke. Atherosclerosis 2009; 204: e58-e63.
16. Abraham JE, Harrington P, Driver KE et al: Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival. Clin Cancer Res 2009; 15: 2181-2191.
17. Iwai N, Tago N, Yasui N et al: Genetic analysis of 22 candidate genes for hypertension in the Japanese population. J Hypertens 2004; 22: 1119-1126. (Pubitemid 38721003)
18. Arnett FC, Edworthy SM, Bloch DA et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324. (Pubitemid 18091653)
19. Klareskog L, Stolt P, Lundberg K et al: A new model for an etiology of rheumatoid arthritis. Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38-46. (Pubitemid 43122184)
20. van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC: The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003; 21 (Suppl 31): S100-S105. (Pubitemid 37265597)
21. Plenge RM, Seielstad M, Padyukov L et al: TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-1209. (Pubitemid 47443179)
22. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-182. (Pubitemid 36177070)
23. Helmersson J, Arnlov J, Axelsson T, Basu S: A polymorphism in the cyclooxygenase 1 gene is associated with decreased inflammatory prostaglandin F2alpha formation and lower risk of cardiovascular disease. Prostaglandins Leukot Essent Fatty Acids 2009; 80: 51-56.
24. Lee KH, Kim HS, El-Sohemy A, Cornelis MC, Uhm WS, Bae SC: Cyclooxygenase-2 genotype and rheumatoid arthritis. J Rheumatol 2006; 33: 1231-1234. (Pubitemid 44025131)
25. Yun HR, Lee SO, Choi EJ, Shin HD, Jun JB, Bae SC: Cyclooxygenase-2 polymorphisms and risk of rheumatoid arthritis in Koreans. J Rheumatol 2008; 35: 763-769. (Pubitemid 351747114)
26. The Wellcome Trust Case Control Consortium: Genome-wide association study of14000. cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
27. Zhuang JJ, Morris AP: Assessment of sex-specific effects in a genome-wide association study of rheumatoid arthritis. BMC Proc 2009; 3 (Suppl 7): S90.
28. Olsson LM, Lindqvist AK, Kallberg H et al: A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res Ther 2007; 9: R98.
29. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B: Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squamous cell carcinoma. Mutat Res 2009; 663: 52-59.
30. Vogel U, Segel S, Dethlefsen C et al: Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome. Atherosclerosis 2010; 1: 155-162.
31. Murphey LJ, Williams MK, Sanchez SC et al: Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer. Anal Biochem 2004; 334: 266-275. (Pubitemid 39370961)
32. Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, Fitzgerald GA: Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest 2006; 116: 1391-1399.
33. Sullivan JC, Sasser JM, Pollock DM, Pollock JS: Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension 2005; 45: 406-411. (Pubitemid 40315811)
34. Francois H, Coffman TM: Prostanoids and blood pressure: which way is up? J Clin Invest 2004; 114: 757-759. (Pubitemid 39578732)
35. Audoly LP, Tilley SL, Goulet J et al: Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. Am J Physiol 1999; 277: H924-H930. (Pubitemid 29459605)
36. Degousee N, Angoulvant D, Fazel S et al: c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytes. J Biol Chem 2006; 281: 16443-16452.